Center for Drug Evaluation and Research growing crisis around HIV testing and treatment and an inter-agency dispute between officials from the former Bureau of Drugs and officials from the former Bureau of Biologics over whether to approve Genentech's Activase (tissue plasminogen activator) led to the split. In its original form, CDER was composed of six offices: Management, Compliance, Drug Standards, Drug Evaluation I, Drug Evaluation II, Epidemiology and Biostatistics, and Research Resources. The Division of Antiviral Products was added in 1989 under Drug Evaluation II due to the large amount of drugs proposed for treating AIDS. The Office of Generic Drugs was also formed. In 2002,
Center for Drug and Alcohol Programs Center for Drug and Alcohol Programs The Center for Drug and Alcohol Programs (CDAP) at Medical University of South Carolina (MUSC) is located in Charleston. The center provides treatment and research for drug, alcohol and substance addiction. It is one of only 14 National Institutes of Health (NIH) funded Alcohol Research Centers in the United States. In 2012, the Center for Drug and Alcohol Programs, through its affiliation with MUSC’s College of Medicine, ranked as one of America’s Best Graduate Schools for the study of drug and alcohol abuse by the U.S. News and World Report. The director of CDAP